PRAG, 10. Juli 2025 /PRNewswire/ -- Zentiva Group und das globale Pharmaunternehmen Lupin Limited haben eine Lizenz- und Liefervereinbarung über die Vermarktung des Biosimilars von Lupin, einem TNF-alpha-Inhibitor, in mehreren Märkten weltweit geschlossen. Ziel dieser strategischen...
Hence then, the article about zentiva und lupin unterzeichnen lizenz und liefervertrag fur tnf alpha inhibitor biosimilar medikament was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Zentiva und Lupin unterzeichnen Lizenz- und Liefervertrag für TNF-alpha-Inhibitor-Biosimilar-Medikament )
Also on site :
- En medio de la crisis, el Gobierno de Cuba anuncia reformas económicas aunque persisten los obstáculos
- LA28 ticket registration nears deadline as first Olympic qualifiers emerge
- ‘American Idol' 2026: Who Went Home Tonight and Who Made It Through to the Top 14?